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Abstract
Background: Diabetes is associated with declining sexual function in women. However, the
effects of diabetes on genital tissue structure, innervation and function remains poorly
characterized. In control and streptozotocin-treated female rats, we investigated the effects of
diabetes on vaginal blood flow, tissue morphology, and expression of arginase I, endothelial nitric
oxide synthase (eNOS) and cGMP-dependent protein kinase (PKG), key enzymes that regulate
smooth muscle relaxation. We further related these changes with estrogen receptor alpha (ERα)
and androgen receptor (AR) expression.
Results: In addition to significantly elevated blood glucose levels, diabetic rats had decreased mean
body weight, lower levels of plasma estradiol, and higher plasma testosterone concentration,
compared to age-matched controls. Eight weeks after administration of buffer (control) or 65 mg/
kg of streptozotocin (diabetic), the vaginal blood flow response to pelvic nerve stimulation was
significantly reduced in diabetic rats. Histological examination of vaginal tissue from diabetic animals
showed reduced epithelial thickness and atrophy of the muscularis layer. Diabetic animals also had
reduced vaginal levels of eNOS and arginase I, but elevated levels of PKG, as assessed by Western
blot analyses. These alterations were accompanied by a reduction in both ERα and AR in nuclear
extracts of vaginal tissue from diabetic animals.
Conclusion: In ovariectomized (estrogen deficient) animals, previous reports from our lab and
others have documented changes in blood flow, tissue structure, ERα, arginase I and eNOS that
parallel those observed in diabetic rats. We hypothesize that diabetes may lead to multiple
disruptions in sex steroid hormone synthesis, metabolism and action. These pathological events
may cause dramatic changes in tissue structure and key enzymes that regulate cell growth and
smooth muscle contractility, ultimately affecting the genital response during sexual arousal.
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Background
Diabetes has adverse effects on sexual function in women
[1-3]. Symptoms consistent with autonomic neuropathy
have been associated with decreased subjective sexual
arousal in diabetic women [4]. In a recent study, Erol et al.
noted that women with type II diabetes experienced
higher prevalence rates of sexual dysfunction when com-
pared to non-diabetic patients [5]. Approximately 80% of
diabetic patients complained of loss of libido, 60% had
diminished clitoral sensitivity, 50% experienced orgasmic
dysfunction, 40% experienced vaginal discomfort, and
40% experienced vaginal dryness. Similarly, other clinical
studies have demonstrated that women with type I diabe-
tes had a higher prevalence of sexual dysfunction (27%)
than healthy women of similar age (15%) [2]. Type I dia-
betic women experienced higher prevalence of reduced
vasocongestion and reduced vaginal lubrication to erotic
stimuli [2,6]. Thus, these clinical studies suggest that both
type I and type II diabetes impedes the physiological
arousal response in women.
The physiology of vaginal hemodynamics and lubrication
responses associated with sexual arousal is highly depend-
ent on the integrity of tissue structure and function and
involves complex neuro-vascular processes modulated by
various local neurotransmitters, vasoactive agents, sex
steroid hormones and growth factors [7-15]. During sex-
ual arousal, activation of parasympathetic nerves to the
genital organs results in relaxation of the vaginal wall,
increased blood flow, vasocongestion (engorgement),
and production of plasma transudate in the vagina
[16,17]. These events are modulated by the tone of the
smooth muscle in both the vasculature and the muscula-
ris. While the neurogenic mechanisms are incompletely
characterized, adrenergic and nitrergic nerves have been
demonstrated to be important regulators of vascular and
non-vascular smooth muscle tone in the vagina [17].
In laboratory studies, vaginal wall contraction to nore-
pinephrine and relaxation to nitric oxide were both atten-
uated in diabetic animals [8]. Diabetes has also been
reported to reduce epithelial growth and decrease blood
vessel density in the lamina propria of the rat vagina [18].
These changes were also accompanied by increased tissue
fibrosis and elevations in TGF-β1. Thus, laboratory and
clinical studies suggest that diabetes-induced alterations
in neural and vascular systems may bring about patho-
physiological changes that impact negatively on sexual
function. However, such studies are few in number and
limited in scope.
Accumulating evidence suggests that estradiol may protect
against diabetic complications [19-21]. Given the impor-
tant role of estradiol in the maintenance of vaginal health
and function, studying the role of estrogens in diabetes
with regard to vaginal physiology provides an interesting
point of convergence for the physiology of steroid hor-
mones and the pathophysiology of diabetes. The effects of
diabetes on vaginal tissue structure, innervation and func-
tion remains poorly characterized and little is known
regarding the effects of diabetes on the regulation of
expression or function of sex steroid receptors and
enzymes that synthesize neurotransmitters (e.g. nitric
oxide synthase). The objective of this study was to investi-
gate the effects of diabetes on vaginal blood flow, tissue
morphology, and expression of key biochemical markers
in the animal model that may be important for vaginal
vasocongestion and lubrication responses during sexual
arousal. Using streptozotocin-treated female rats, a widely
used model of type I diabetes, we examined changes in the
levels of arginase I, endothelial nitric oxide synthase
(eNOS) and cGMP-dependent protein kinase (PKG) due
to their roles in modulating smooth muscle relaxation
[11-13,22-25]. We further related these changes with
estrogen receptor expression and function.
Table 1: Blood glucose, body and tissue weights, and plasma hormone concentrations of control and diabetic rats. Female Sprague-
Dawley rats, at 8–10 weeks of age, were fasted for 18–24 h and administered 0.02 M citrate saline buffer (Control) or streptozotocin 
(65 mg/kg) in citrate buffer (Diabetic) by intraperitoneal injection. All parameters shown below were determined 8 weeks after the 
administration of streptozotocin or buffer. Comparisons between groups were performed using unpaired t-test and two-tailed p 
values are listed below each parameter examined.
Blood Glucose 
(mg/dL)
Body Weight 
(g)
Uterine Weight 
(mg)
Vaginal Weight 
(mg)
Vaginal Length 
(mm)
Plasma Hormone Conc.
Estradiol 
(pg/mL)
Testosterone 
(pg/mL)
Control 
(n = 11)
68.7 ± 2.2 281.2 ± 6.1 644.8 ± 55.3 238.1 ± 10.5 20.0 ± 0.9 58.3 ± 4.4 185.8 ± 15.8
Diabetic 
(n = 12)
497.6 ± 28.0 247.1 ± 8.5 437.4 ± 57.2 237.7 ± 9.5 18.7 ± 0.3 47.3 ± 3.1 281.2 ± 28.4
P (two-tailed) <0.0001 0.0048 0.0183 0.9776 0.1644 0.0508 0.0146BMC Physiology 2006, 6:4 http://www.biomedcentral.com/1472-6793/6/4
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Results
Physiological parameters and vaginal blood flow
Administration of streptozotocin resulted in significant
elevations (≥ 7-fold) in blood glucose levels after 2 weeks
that were sustained throughout the duration of the study
(Table 1). On average, rats had a mean body weight of 209
± 6 g at the beginning of the study. Although diabetic ani-
mals on normal diet gained weight after 8 weeks (18%
increase), they gained less weight than control animals
(35% increase) and had significantly lower body weights
when compared to controls (Table 1). Interestingly, while
vaginal weight and length were similar for both treatment
groups, uteri from diabetic rats were significantly smaller
and had lower wet weights relative to control animals. In
addition, diabetic animals had a lower concentration of
estradiol and a higher concentration of testosterone in
plasma samples.
Blood flow in the vagina was assessed by laser Doppler
flowmetry. In control rats, vaginal blood flow in response
to pelvic nerve stimulation was proportional to the stim-
ulation frequency (Figure 1). However, in diabetic ani-
mals, the amplitude of the blood flow response was
significantly reduced (Figures 1 & 2) and was not always
proportional to the frequency of nerve stimulation. In
addition, the duration of each nerve-stimulated response
tended to be shorter and the basal blood flow in the
absence of nerve stimulation was lower in diabetic ani-
mals. To factor in the contribution of any changes in sys-
temic blood pressure, we also calculated the vascular
resistance in the vagina. Vascular resistance was character-
istically decreased in response to stimulation of the pelvic
nerve. Whether vascular resistance was assessed by the
area under the curve or the average peak response, dia-
betic animals exhibited a significant attenuation in this
parameter of vaginal perfusion (Figure 2).
Vaginal tissue morphology
Although mean vaginal tissue wet weights and lengths
were similar in both control and diabetic groups, vaginas
from diabetic rats appeared atrophic upon gross examina-
tion. To further study potential diabetes-induced changes,
vaginal tissue sections were subjected to Masson's tri-
chrome staining. This procedure stains cellular material
purple-red and extracellular material (primarily connec-
tive tissue) blue-green (Figure 3). In control animals, the
thickness of the epithelium varied, depending on the stage
of the estrous cycle when the tissue was removed and
fixed. Examination of vaginal smears indicated that
almost half (5/11) of the control rats were in diestrus,
with the remaining animals evenly distributed between
proestrus, estrus and metestrus (2/11 for each stage). In all
control animals, irrespective of the estrous cycle stage, the
muscularis layer consisted of large, well-defined bundles
of smooth muscle (Figure 3).
In the diabetic group, 75% of the animals (9/12) were in
diestrus, 2 rats were in metestrus, 1 rat was in estrus, and
none were in proestrus. Vaginal tissue cross-sections from
diabetic rats tended to have epithelium that was more uni-
formly thin with fewer layers of cells, relative to control
animals. Most strikingly, the muscularis layer was consist-
ently thin with less well developed bundles, suggesting
atrophy (Figure 3). Alterations to the lamina propria were
not evident. However, the use of more specific immunos-
taining would be required to detect changes in blood ves-
sel structure or density.
Protein expression of biochemical markers related to 
vaginal hemodynamics
To further characterize potential mechanisms that might
be responsible for the decreased vaginal blood flow in dia-
betic rats, we examined the protein levels of arginase I,
Effect of diabetes on vaginal blood flow in rats Figure 1
Effect of diabetes on vaginal blood flow in rats. Female 
Sprague-Dawley rats, at 8–10 weeks of age, were fasted for 
18–24 h and administered 0.02 M citrate saline buffer (Con-
trol) or streptozotocin (65 mg/kg) in citrate buffer (Diabetic) 
by intraperitoneal injection. After 8 weeks, rats were anes-
thetized and the vaginal blood flow response to pelvic nerve 
stimulation was recorded by laser Doppler flowmetry. The 
pelvic nerve was stimulated for 30 seconds at 5, 10, and 20 
Hz. Shown are representative real time recordings of vaginal 
blood flow (black) expressed as tissue perfusion units (TPU; 
left axis) and systemic arterial pressure (gray) expressed as 
millimeters of Hg (right axis).BMC Physiology 2006, 6:4 http://www.biomedcentral.com/1472-6793/6/4
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endothelial nitric oxide synthase (eNOS), and cGMP-
dependent protein kinase (PKG); key enzymes that are
known to regulate vascular smooth muscle tone within
the vagina. On average, levels of arginase I protein
decreased by 57% and eNOS protein decreased by 40% in
vaginal tissue from diabetic rats, relative to age-matched
controls (Figure 4). However, PKG protein levels in the
vagina increased approximately 2-fold in the diabetic
group, relative to the control group.
Expression of estrogen and androgen receptors
In light of the changes in the plasma concentration of
estradiol and testosterone in diabetic rats, we investigated
the effects of diabetes on the protein levels of estrogen and
androgen receptors in the vagina. Nuclear extracts were
examined by Western blot analyses to determine levels of
hormone-activated receptor. On average, ERα decreased
in vaginal tissue from diabetic rats by 51% and AR protein
levels decreased by 69% when compared to age-matched
controls (Figure 5).
Discussion
These data suggest that the diabetic state produces dra-
matic changes in vaginal tissue structure and function,
characterized by decreased blood flow, atrophy of the
muscularis and attenuation of epithelial proliferation.
These changes were also accompanied by alterations in
sex steroid hormone receptors and key enzymes that regu-
late blood flow. Previous studies in the rat demonstrated
that preservation of normal vaginal tissue structure and
blood flow are dependent upon estrogen signaling
[13,26]. On a gross level, the histological and physiologi-
cal changes in the present study resemble those observed
in vaginal tissue from ovariectomized animals in previous
studies [13,15,26]. Similar to ovariectomized animals,
mean plasma estradiol concentration and mean uterine
wet weight was decreased in the diabetic group. However,
unlike ovariectomized animals, plasma testosterone levels
were significantly elevated in the diabetic group. While
the reasons for this increase remain unclear, previous
studies have demonstrated that ovarian aromatase activity
is insulin-dependent [27-29]. In the STZ-induced diabetic
rat, the lack of insulin production may inhibit aromatase
activity, causing an increase in testosterone due to
decreased estrogen biosynthesis. In addition, female rats
repeatedly subjected to physical and psychological stress
protocols are reported to have significantly elevated
plasma testosterone [30], suggesting that increased testo-
sterone may be part of a systemic stress response.
It remains to be established whether the lower levels of
circulating plasma estradiol are responsible for the
changes in the diabetic rats. Yet, given that vaginal tissue
from diabetic animals exhibited decreased ERα protein in
the nucleus, it is likely that additional mechanisms that
interfere with estrogen receptor signaling are triggered.
This perspective is further supported by the observation
that in vaginal tissue of ovariectomized animals, ERα
increases in the nuclear compartment but decreases in the
cytosolic compartment [13]. If decreased plasma estradiol
Summarized data for vaginal blood flow Figure 2
Summarized data for vaginal blood flow. Vaginal blood flow 
was measured in control (open bars) and diabetic groups 
(solid bars) of female rats (see Figure 1). Responses to pelvic 
nerve stimulation were analyzed by calculating the area-
under-the-curve (AUC) for vascular resistance (systemic 
arterial pressure/blood flow) and the percent change in peak 
vascular resistance and vaginal blood flow (VBF). Data are the 
mean ± SEM. *p < 0.05 versus control group.BMC Physiology 2006, 6:4 http://www.biomedcentral.com/1472-6793/6/4
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alone were responsible for the alterations in vaginal tissue
structure and function, one would expect similar intracel-
lular distributions of ERα in both diabetic and ovariect-
omized animals. Since the severity and duration of
estrogen deficiency is different in the ovariectomized rat,
additional studies are necessary to define the time course
of changes in the diabetic rat and the dose-response rela-
tionship between estrogen and vaginal structure and func-
tion. The decreased levels of nuclear AR in diabetic rat
vaginal tissue suggests that testosterone action may also
be disrupted in the diabetic state. While testosterone has
been shown to affect adrenergic nerve density in the rat
vagina [26], the role of androgens in regulating vaginal
structure and function in diabetes remains to be exam-
ined.
Further parallels between the diabetic and ovariectomized
states are highlighted by the reductions in arginase I and
eNOS in vaginal tissue. Previous studies have shown that
arginase in rabbit vagina [31] and eNOS in rat vagina [32]
are decreased in ovariectomized animals and up-regulated
after estrogen administration. However, some of these
changes appear to be tissue and species specific, since
estradiol can have the opposite effect on eNOS expression
or activity in rabbits [33,34]. While arginase has been
shown to modulate vascular responses in female genital
tissue, it has also been shown in other tissues to be critical
for regulating cell growth [35,36]. Lower arginase levels
may be partially responsible for the atrophic appearance
of the vaginal muscularis and epithelium in diabetic ani-
mals. In addition, arginase activity can decrease NO syn-
thesis through substrate competition (i.e. by decreasing
intracellular arginine pools) and the lower levels of argin-
ase in diabetic rat vagina may also be reflective of a com-
pensatory down-regulation in the local vasculature to
maintain basal perfusion.
This compensatory response may also involve the
observed changes in PKG. Since PKG mediates the intrac-
ellular response to NO, decreased NO production and/or
increased NO scavenging in diabetic animals could lead
to a compensatory up-regulation in PKG. Alternatively,
the protein level and enzyme activity of PKG have been
reported to increase in the lung following chronic hypoxia
[37]. It is possible that decreased blood flow to the vagina
in diabetic animals may have produced hypoxic condi-
tions that triggered the up-regulation of PKG. Interest-
ingly, PKG was significantly decreased in penile tissue of
diabetic male rabbits [38]. This contrasting finding may
be attributed to any number of differences, including tis-
sue, species, sex, duration of diabetes or mechanism of
function.
Thus, data from the current study, together with our pre-
vious findings, suggest that diabetes may adversely affect
estrogen production and/or ER signaling. This hypothesis
is derived from several lines of evidence that include par-
allel changes with regard to blood flow, tissue structure,
and protein expression of arginase and eNOS that are
observed in both diabetic and ovariectomized (estrogen
deficient) animals. The dissimilar changes of nuclear ERα
levels in diabetic and ovariectomized animals, and the
observation that many diabetic rats are in diestrus (phase
of estrous cycle with lowest estrogen level), further sup-
port a pathophysiological mechanism that includes dis-
ruptions in estrogen action.
Previous laboratory studies have indicated that diabetes
disrupts estrogen signaling in a variety of tissues. In the
pituitary of diabetic animals, ER binding was reduced and
ERα levels decreased, potentially affecting sexual receptiv-
ity and reproduction [39,40]. Nuclear retention of estra-
diol-bound ER has been shown to be of shorter duration
in both the pituitary and uteri of diabetic animals [41,42].
Further, pituitary responsiveness to LH-RH was reduced,
inhibiting ovulation in diabetic animals [43]. In STZ-
induced diabetic mice, estradiol restored cell proliferation
in the dentate gyrus and subventricular zone [44] and
high glucose has been shown to block the effects of estra-
diol in human vascular cell growth [45]. Diabetes is also
known to adversely affect renal function and estradiol
treatment counteracts this pathophysiological effect in
diabetic animals [46]. More specific investigation into dis-
ease mechanisms affecting ER regulation indicate that oxi-
Effect of diabetes on overall vaginal tissue structure Figure 3
Effect of diabetes on overall vaginal tissue structure. Vaginal 
tissue sections (5 μm) from control (CN) and diabetic (DB) 
rats (see Figure 1) were subjected to a modified Masson's tri-
chrome staining procedure. Shown are representative tissue 
sections from 3 separate animals for each treatment group. 
For each panel, the epithelium (Epi) and muscularis (Musc) 
layers are identified by the arrows. Magnification = 240 ×BMC Physiology 2006, 6:4 http://www.biomedcentral.com/1472-6793/6/4
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dative stress, a well-known consequence of diabetes,
differentially regulates the expression of ERα and ERβ in
different cell types [47]. Thus, the diabetic state may cause
dysregulation of estrogen action within both central and
peripheral estrogen-sensitive tissues.
It should be noted that our study is a preliminary report
and has several important limitations. Histological
changes in the vagina were only assessed on a gross level
and not analyzed by objective morphometric methods.
More detailed studies examining diabetes-induced struc-
tural changes in the vagina are currently planned. These
studies would quantitatively determine structural changes
in the various layers of the vagina, blood vessel density,
innervation, etc. Further, since the Western blot assays
were performed with whole tissue extracts, the cellular
localization of the biochemical markers that were exam-
ined in this study remains unclear. Immunohistochemical
staining of these markers would provide additional infor-
mation pertinent to the effects of diabetic impairment of
vaginal function. Future histological studies should also
examine changes in structure and protein expression in
different regions of the vagina. Only tissue sections from
the mid-vagina were used in the current study since this is
the region where blood flow was measured. Also, tissues
from multiple animals in each treatment group were
pooled for Western blot analyses. Values reported as per-
cent change (relative to control) were intended to be
indicative of general trends and should not be taken as
exhaustive quantitative determinations. Finally, vaginal
smears were not performed daily to assess potential dis-
ruptions in the estrous cycle and the increased number of
diabetic rats in diestrus may have been purely coinciden-
tal. However, the decrease in plasma estradiol and uterine
weight, the general atrophic appearance of the vagina, and
the reduced levels of nuclear ERα in vaginal tissue of dia-
betic animals are consistent observations that are sugges-
tive of disruptions in steroid hormone synthesis and
signaling. We did not determine ERβ levels in our study
since ERα has been shown to be the predominant subtype
expressed in the rat vagina [48].
While the data from this study are limited in their inter-
pretation with respect to the clinical state of diabetes, this
model provides data supporting clinical observations of
decreased genital arousal in women with diabetes melli-
tus. If indeed STZ-induced diabetes in the rat disrupts
estrogen signaling, then it would be logical to investigate
in future studies the role of estrogen therapy in diabetes to
ameliorate the complications of diabetes.
Conclusion
In summary, we hypothesize that STZ-induced diabetes
leads to multiple disruptions in sex steroid hormone syn-
thesis, metabolism and action. In the vagina, diabetes
causes a significant reduction in blood flow. This patho-
logical alteration in a critical component of the genital
response during sexual arousal is accompanied by dra-
matic changes in tissue structure and key enzymes that
regulate cell growth and smooth muscle contractility.
Future studies should address these molecular events in
greater detail and examine the potential sex specific nature
of diabetic manifestations.
Methods
Animals
Mature female Sprague-Dawley rats (strain Crl:CD; 8–10
weeks old; 200–225 g) were purchased from Charles River
Laboratories (Wilmington, MA) and used for investiga-
tion of the effects of diabetes on vaginal physiology. These
studies were approved by the Institutional Animal Care
and Use Committee at the Boston University School of
Medicine. Animals were fasted for 18–24 h and streptozo-
tocin (STZ; 65 mg/kg) in 0.02 M citrate saline buffer was
administered intraperitoneally, as described previously
[8,18,49]. The age-matched control group received citrate
buffer only. Blood glucose levels were monitored every 2
weeks using an Accu-check blood glucose meter (Roche
Diagnostics, Basel, Switzerland). Rats with blood glucose
levels ≥ 15 mM (200 mg/dl) for 2 consecutive weeks were
considered diabetic. Eight weeks after the initial adminis-
tration of streptozotocin or buffer, in vivo studies were car-
ried out to assess vaginal blood flow, as described below.
Assessment of estrus cycle phase
For all intact animals, smears of vaginal cells were pre-
pared before vaginal blood flow measurements. A cotton
swab moistened in 0.9% saline was inserted into the
Effect of diabetes on arginase I, eNOS, and PKG protein  expression in the rat vagina Figure 4
Effect of diabetes on arginase I, eNOS, and PKG protein 
expression in the rat vagina. Vaginal tissues from diabetic 
(Diab) or age-matched control (Con) rats were homoge-
nized and the cytosolic fraction was obtained by differential 
centrifugation. The vaginal tissue cytosolic extract (200μg 
total protein/lane) was then subjected to gel electrophoresis 
under denaturing conditions. Gels were blotted onto nitro-
cellulose membranes that were probed with primary anti-
bodies against arginase I, eNOS and PKG. After incubation 
with the secondary antibody, membranes were developed 
using an enhanced chemiluminescence reaction and bands 
were visualized by exposure to film.BMC Physiology 2006, 6:4 http://www.biomedcentral.com/1472-6793/6/4
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vagina, manipulated in a circular fashion and then
smeared onto a glass slide. Samples were fixed with 70%
ethanol and stained with hematoxylin and CytoQuik
stain (Fisher Scientific). The phase of the estrous cycle was
determined from the morphological characteristics of the
vaginal cells. All samples were coded to mask the treat-
ment groups and evaluations were performed by a
licensed cytologist. The actual estrous phase of each ani-
mal remained unknown to the investigators until data
analysis was complete.
In vivo assessment of vaginal blood flow
Changes in vaginal blood flow in response to pelvic nerve
stimulation were determined by laser Doppler flowmetry,
as previously described [12,13]. Briefly, rats were anesthe-
tized with intramuscular injections of ketamine (40 mg/
kg) and xylazine (4 mg/kg). To continuously monitor sys-
temic blood pressure, a 24-gauge angiocatheter was intro-
duced into the carotid artery and connected to a pressure
channel of the laser Doppler flowmeter (Model BLF21D,
Transonic Systems, Inc., Ithaca, NY). A surface probe
(Type I; Transonic Systems, Inc.) was placed in the vaginal
canal, facing the anterolateral vaginal wall and approxi-
mately halfway between the introitus and the cervix. Uni-
lateral pelvic nerve stimulation (PNS) was accomplished
with a Grass S9 stimulator set at normal polarity and
repeat mode to generate a 30 second train of square waves
with 6 Volt pulse amplitude and 0.8 millisecond pulse
duration at various frequencies (5, 10, 20 Hz). Blood flow
data were recorded as tissue perfusion units (TPU).
Hemodynamic parameters (vaginal blood flow and sys-
temic blood pressure) were continuously recorded (col-
lection rate = 100 Hz) throughout the experiment using
WinDaq software (version 2.15; Dataq Instruments,
Akron, OH). Since blood flow through any given tissue is
dependent upon the systemic blood pressure, we also cal-
culated the instantaneous vascular resistance (systemic
blood pressure/blood flow) at each time point. Using the
vascular resistance plots, the area under the curve (AUC)
for each response was determined. The results were
expressed as mean ± S.E.M. Comparisons between treat-
ment groups were analyzed by unpaired t-tests. Means
were considered significantly different if the two-tailed p-
value was less than 0.05.
Measurement of plasma hormones
Blood was drawn at the end of the vaginal blood flow
studies. Plasma samples were sent to the Endocrinology
Laboratory, Animal Health Diagnostic Center at the Cor-
nell University College of Veterinary Medicine (Ithaca,
NY) for determination of estradiol and testosterone levels.
A solid-phase radioimmunoassay (RIA) with Coat-A-
Count reagents (Diagnostic Products Corp., Los Angeles,
CA) was used, as previously described [50].
Tissue procurement
After the completion of the in vivo studies, animals were
exsanguinated and vaginal and uterine tissues were
removed in their entirety, weighed and placed in chilled
physiological salt solution. For histological analyses, vagi-
nas (5 animals per group) were opened with a longitudi-
nal incision and a small notch was cut at the distal end for
proper orientation. Tissues were then immersed in 10%
neutral buffered formalin and stored at 4°C for 24–72
hours. For biochemical studies, vaginal tissues from con-
trol (n = 6) or diabetic (n = 7) animals were frozen in liq-
uid nitrogen and stored at -80°C until assayed.
Histology
After fixation, the mid-section of each vagina was embed-
ded in paraffin and subsequently sectioned at 5 microns
using a rotary microtome. Tissue sections were deparaffi-
nized with CitriSolv (Fisher Scientific, Pittsburgh, PA),
rehydrated in graded ethanol solutions (100–70%), and
subjected to a modified Masson's trichrome staining pro-
cedure, as previously described [26].
Preparation of cytosolic and nuclear extracts from vaginal 
tissue
Frozen vaginal tissue was pulverized with a Bessman tis-
sue pulverizer (Spectrum Laboratories, Rancho
Dominguez, CA) cooled on dry ice. Tissue powder from
each treatment group was pooled and combined (1 g/4
Effect of diabetes on nuclear estrogen receptor alpha (ERα)  and androgen receptor (AR) in the rat vagina Figure 5
Effect of diabetes on nuclear estrogen receptor alpha (ERα) 
and androgen receptor (AR) in the rat vagina. Vaginal tissues 
from diabetic (Diab) or age-matched control (Con) rats were 
homogenized and the nuclear subcellular fraction was 
obtained by differential centrifugation. ERα was extracted 
from the nuclei by homogenization and incubation in high salt 
buffer. The vaginal tissue nuclear extract (200 μg total pro-
tein/lane) was then subjected to gel electrophoresis under 
denaturing conditions. Gels were blotted onto nitrocellulose 
membranes that were probed with antibody against ERα or 
AR. After incubation with the secondary antibody, mem-
branes were developed using an enhanced chemilumines-
cence reaction and bands were visualized by exposure to 
film.BMC Physiology 2006, 6:4 http://www.biomedcentral.com/1472-6793/6/4
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ml) with ice cold buffer (20 mM HEPES, pH 7.4, 1 mM
EDTA, 0.25 M sucrose). After the addition of phenylmeth-
ylsulfonylfluoride (PMSF; 0.5 mM) and mammalian pro-
tease inhibitor cocktail (1 mM AEBSF, 0.08 μM aprotinin,
20 μM leupeptin, 40 μM bestatin, 15 μM pepstatin A and
14 μM E-64; Sigma Chemical Co., St. Louis, MO), tissue
powder was homogenized on ice using a Brinkmann
PT3000 polytron with 10 second bursts and 30 second
cooling intervals. The homogenate was centrifuged at
3000 × g for 20 min at 4°C and the supernatant (cytosol)
was transferred to a fresh tube. An aliquot was used to
determine soluble protein concentration and the rest of
the cytosolic extract was frozen at -20°C until further
assay. The pellet containing the nuclei was resuspended in
ice cold buffer (50 mM Tris-HCl, pH 7.4 at 22°C, 1.5 mM
sodium EDTA, 10% glycerol, 10 mM sodium molybdate
and 10 mM monothioglycerol) containing 0.4 M KCl and
homogenized on ice with a Dual glass-glass homogenizer
using a motor driven pestle. The nuclear homogenate was
incubated on ice for 1 hour and centrifuged at 100,000 ×
g for 30 minutes. The resulting supernatant (nuclear
extract) was transferred to a new tube and frozen at -20°C.
Western blot analyses
Western blot analyses were performed on cytosolic
extracts of vaginal tissue to assess changes in arginase I,
endothelial nitric oxide synthase (eNOS), and cGMP-
dependent protein kinase (PKG). Nuclear extracts of vagi-
nal tissue were used to assess changes in estrogen receptor
alpha (ERα) and androgen receptor (AR). Aliquots of vag-
inal tissue extract (200 μg/lane) were electrophoresed on
7.5% polyacrylamide/10% SDS gels under denaturing
conditions and transferred to nitrocellulose membranes.
Membranes were incubated for 1 hr in blocking buffer
and then incubated at 4°C for 16–20 hr in primary anti-
body on a rocking platform. The following primary anti-
bodies were used: rabbit polyclonal anti-arginase I (H-52;
Santa Cruz Biotechnology, Inc., Santa Cruz, CA), mouse
monoclonal anti-eNOS IgG1 (clone 3; BD Transduction
Laboratories, Franklin Lanes, NJ), rabbit polyclonal anti-
PKG (Stressgen Biotechnologies, Victoria, BC, Canada),
rabbit monoclonal anti-ERα (clone SP1, catalog
#RM9101; Lab Vision Corp., Fremont, CA), and rabbit
polyclonal anti-AR (PA1-111A; Affinity BioReagents,
Golden, CO). All antibodies were used at the dilutions
recommended by their respective suppliers. Membranes
were washed and incubated with either horseradish per-
oxidase-linked goat anti-rabbit IgG or goat anti-mouse
IgG secondary antibody (Pierce Chemical Co., Rockford,
IL). After washing, membranes were developed with an
enhanced chemiluminescence (ECL) kit (Pierce Chemical
Co.) and exposed to autoradiographic film. Band inten-
sity was quantified with Image J, a public domain Java
image processing program [51].
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